Artículos por temáticas

Mechanism of the neuroprotective effect of injecting brain cells on ST36 in an animal model of Parkinson's disease

Song J, Lee SS, Lim S, Yeo S.

Neurosci Lett. 2020 Jan 19;717:134698. doi: 10.1016/j.neulet.2019.134698. Epub 2019 Dec 16.

Obstructive sleep apnea, CPAP therapy and Parkinson's disease motor function: A longitudinal study

Meng L, Benedetti A, Lafontaine AL, Mery V, Robinson AR, Kimoff J, Gros P, Kaminska M.

Parkinsonism Relat Disord. 2020 Jan;70:45-50. doi: 10.1016/j.parkreldis.2019.12.001. Epub 2019 Dec 2.

The gut in Parkinson's disease: Bottom-up, top-down, or neither?

Leclair-Visonneau L, Neunlist M, Derkinderen P, Lebouvier T.

Neurogastroenterol Motil. 2020 Jan;32(1):e13777. doi: 10.1111/nmo.13777.

Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1)

Wilson H, Pagano G, Yousaf T, Polychronis S, De Micco R, Giordano B, Niccolini F, Politis M.

J Neural Transm (Vienna). 2020 Jan;127(1):51-59. doi: 10.1007/s00702-019-02125-6. Epub 2019 Dec 18.

Brainstem-Predominant Lewy-Related Pathology in a Patient with Parkinson's Disease without Dementia

Choi JH, Park SH, Park SS, Jeon B.

J Mov Disord. 2020 Jan;13(1):74-76. doi: 10.14802/jmd.19059. Epub 2019 Dec 19.

Synergic control of action in levodopa-naïve Parkinson's disease patients: I. Multi-finger interaction and coordination

de Freitas PB, Freitas SMSF, Reschechtko S, Corson T, Lewis MM, Huang X, Latash ML.

Exp Brain Res. 2020 Jan;238(1):229-245. doi: 10.1007/s00221-019-05709-6. Epub 2019 Dec 14.

Alzheimer's Disease and Parkinson's Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and Environmental Chemicals

Agnihotri A, Aruoma OI.

J Am Coll Nutr. 2020 Jan;39(1):16-27. doi: 10.1080/07315724.2019.1683379. Epub 2019 Dec 12.

Gait bradykinesia: difficulty in switching posture/gait measured by the anatomical y-axis vector of the sole in Parkinson's disease

Warabi T, Furuyama H, Kato M.

Exp Brain Res. 2020 Jan;238(1):139-151. doi: 10.1007/s00221-019-05704-x. Epub 2019 Dec 10.

α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model

Taguchi T, Ikuno M, Hondo M, Parajuli LK, Taguchi K, Ueda J, Sawamura M, Okuda S, Nakanishi E, Hara J, Uemura N, Hatanaka Y, Ayaki T, Matsuzawa S, Tanaka M, El-Agnaf OMA, Koike M, Yanagisawa M, Uemura

Brain. 2020 Jan 1;143(1):249-265. doi: 10.1093/brain/awz380.

Psychiatric Patients on Neuroleptics: Evaluation of Parkinsonism and Quantified Assessment of Gait.

Yahalom H, Israeli-Korn S, Linder M, Yekutieli Z, Karlinsky KT, Rubel Y, Livneh V, Fay-Karmon T, Hassin-Baer S, Yahalom G.

Clin Neuropharmacol. 2020 Jan/Feb;43(1):1-6. doi: 10.1097/WNF.0000000000000371.

Experience and Impact of OFF Periods in Parkinson's Disease: A Survey of Physicians, Patients, and Carepartners

Rastgardani T, Armstrong MJ, Gagliardi AR, Grabovsky A, Marras C.

J Parkinsons Dis. 2020;10(1):315-324. doi: 10.3233/JPD-191785.

Is Aquatic Therapy Optimally Prescribed for Parkinson's Disease? A Systematic Review and Meta-Analysis

Carroll LM, Morris ME, O'Connor WT, Clifford AM.

J Parkinsons Dis. 2020;10(1):59-76. doi: 10.3233/JPD-191784.

Tau Tangles in Parkinson's Disease: A 2-Year Follow-Up Flortaucipir PET Study

Hansen AK, Parbo P, Ismail R, Østergaard K, Brooks DJ, Borghammer P.

J Parkinsons Dis. 2020;10(1):161-171. doi: 10.3233/JPD-191774.

Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort

Graham OEE, Pitcher TL, Liau Y, Miller AL, Dalrymple-Alford JC, Anderson TJ, Kennedy MA.

Parkinsonism Relat Disord. 2020 Jan;70:36-41. doi: 10.1016/j.parkreldis.2019.11.022. Epub 2019 Nov 29.

New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson's disease

Keir LHM, Breen DP.

J Neurol. 2020 Jan;267(1):288-294. doi: 10.1007/s00415-019-09651-z. Epub 2019 Dec 5.